--- title: "GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-year" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/254603407.md" description: "GLORIA PHARMA announced that in the first half of 2025, the company achieved operating revenue of 1.1 billion yuan, a year-on-year decrease of 9.97%; the net profit attributable to shareholders of the listed company was 134 million yuan, a year-on-year increase of 7.56%; basic earnings per share were 0.0613 yuan/share, a year-on-year increase of 10.25%" datetime: "2025-08-26T10:40:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/254603407.md) - [en](https://longbridge.com/en/news/254603407.md) - [zh-HK](https://longbridge.com/zh-HK/news/254603407.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/254603407.md) | [English](https://longbridge.com/en/news/254603407.md) # GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-year GLORIA PHARMA announced that in the first half of 2025, the company achieved operating revenue of 1.1 billion yuan, a year-on-year decrease of 9.97%; the net profit attributable to shareholders of the listed company was 134 million yuan, a year-on-year increase of 7.56%; the basic earnings per share were 0.0613 yuan/share, a year-on-year increase of 10.25% ### 相關股票 - [GLORIA PHARMA. (002437.CN)](https://longbridge.com/zh-HK/quote/002437.CN.md) ## 相關資訊與研究 - [Tennis-Sabalenka too hot for Osaka as the world number one reaches Indian Wells quarters](https://longbridge.com/zh-HK/news/278607881.md) - [Qyuns Therapeutics' Arthritis Drug Crusekitug Accepted for Review in China; Shares Jump 11%](https://longbridge.com/zh-HK/news/278491064.md) - [Daily Multivitamins May Slow Biological Aging In Older Adults, Study Finds](https://longbridge.com/zh-HK/news/278604286.md) - [Tennis-Djokovic reaches Indian Wells last 16 as Pegula fights back to progress](https://longbridge.com/zh-HK/news/278446416.md) - [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/zh-HK/news/278461777.md)